SITC Resource Library

On November 21, 2024, the Society for Immunotherapy of Cancer (SITC) held the sixth webinar in the new series "Increasing Access to IO: A Global Webinar Series". The recording of the sixth webinar "Tumor Biomarkers and Assessing PD-L1: Increasing Access to IO" is available below.
sdaf

Webinar Moderator

• Paolo Ascierto, MD – Instituto Nazionale Tumori IRCCS Foundazoine G. Pascale
  
  

Webinar Faculty

• Jyoti Bajpai, MD, DM – Apolloi Hospital Navi Mumbai and Maharashtra
• Danny Khalil, MD, PhD – Memorial Sloan Kettering Cancer Center
• Taha Merghoub, PhD – Weill Cornell Medicine

Program Information

The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, is pleased to launch SITC’s first educational program crafted specifically for international audiences, titled “Increasing Access to IO: A Global Webinar Series”. These free digital events will provide a forum for physicians around the globe to discuss challenges and solutions related to critical topics, such as defining biomarkers for PD-L1 positive patients, biomarker assessment for tumor response, cellular therapy and checkpoint inhibitor administration, tumor mutational burden (TMB) and more. Featuring doctors from varying settings around the world, this webinar series offers a unique opportunity to learn about different solutions to immunotherapy application and the barriers currently impeding equitable access to IO. The objective of this webinar series is to create a platform for international stakeholders to discuss critical topics and challenges they face when treating patients with immunotherapy, with a key goal of providing education and bringing awareness to the barriers currently impeding equitable access to IO around the globe. 

#PresentationSlides#RecordedWebinar
#2024